Columbus Venture Partners

Columbus Venture Partners is a Spanish venture capital firm specializing in life sciences, investing in and developing breakthrough biotechnological therapies. It provides seed funding to early-stage biotech startups, uniquely combining capital with infrastructure creation. This integrated approach builds complete value chains, accelerating development timelines within the biotech sector.

Co-founded in 2015 by Damià Tormo, a biologist, and Javier García, a mathematician with executive experience at Eli Lilly, the firm's inception stemmed from a critical insight. They recognized the acute need for effective therapies targeting hard-to-treat and incurable diseases, like cancer. Their ambition was to address these medical challenges through strategic investment and development in Spanish biotech.

Columbus Venture Partners serves limited partners seeking robust financial returns, and innovative biotech companies requiring capital and strategic support to commercialize products. Its long-term vision is to be the foremost life science fund manager in Spain, committed to advancing life-changing biotechnological solutions delivering strong investor value.